Christopher J. Del Orefice
Executive Vice President And Chief Financial Officer
Becton, Dickinson and Company · BDX
$5.9M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed December 18, 2025. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $838K
- Stock Awards
- $3.1M
- Option Awards
- $1M
- Incentives
- $723K
- Other
- $136K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $837,500 | $3,140,481 | $5,877,164 |
| 2024 | $785,400 | $2,689,582 | $5,628,654 |
| 2023 | $736,200 | $2,531,331 | $5,206,390 |
Current Position
- Title
- Executive Vice President And Chief Financial Officer
- Ticker
- BDX · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed December 18, 2025), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0001628280-25-057846.
Other BD Executives
Thomas E. Polen
Chairman, Chief Executive Officer And President
BD · BDX
$17.1M
FY 2025 · DEF 14A
Richard E. Byrd
Executive Vice President And President, Interventional Segment
BD · BDX
$3.4M
FY 2025 · DEF 14A
Michael C. Feld
Executive Vice President, Chief Revenue Officer And President, Life Sciences Segment
BD · BDX
$4.1M
FY 2025 · DEF 14A
Michael D. Garrison
Executive Vice President And President, Medical Essentials And Bio Pharma Systems Segments
BD · BDX
$3.6M
FY 2025 · DEF 14A